| Oct 12, 2017 |
Oct 19, 2017 |
KalVista Pharmaceuticals, Inc.
|
Director |
Buy |
100.0
|
+565,065
|
152.96%
|
✗
|
$4.9M |
| Jun 1, 2016 |
Jun 3, 2016 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+425,000
|
27.61%
|
✗
|
$3M |
| May 18, 2016 |
May 20, 2016 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
82.5
|
+20,000
|
1.32%
|
✗
|
$157.2K |
| May 16, 2015 |
May 18, 2016 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
90.0
|
+40,000
|
2.70%
|
✗
|
$305K |
| May 12, 2016 |
May 16, 2016 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
90.0
|
+36,095
|
2.50%
|
✗
|
$250.4K |
| May 11, 2016 |
May 13, 2016 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
82.5
|
+20,000
|
1.41%
|
✗
|
$152.8K |
| May 10, 2016 |
May 12, 2016 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
82.5
|
+19,900
|
1.42%
|
✗
|
$153.6K |
| Mar 23, 2016 |
Mar 25, 2016 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
90.0
|
+59,800
|
4.46%
|
✗
|
$567.2K |
| Mar 21, 2016 |
Mar 23, 2016 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
90.0
|
+59,800
|
4.66%
|
✗
|
$624.5K |
| Mar 17, 2016 |
Mar 21, 2016 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
90.0
|
+59,700
|
4.88%
|
✗
|
$493K |
| Mar 15, 2016 |
Mar 17, 2016 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
92.5
|
+59,029
|
5.07%
|
✗
|
$466.1K |
| Mar 11, 2016 |
Mar 15, 2016 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+162,732
|
16.26%
|
✗
|
$1.2M |
| Jun 8, 2015 |
Jun 10, 2015 |
PTC THERAPEUTICS, INC.
|
Director |
Sell |
7.5
|
-7,000
|
-100.00%
|
✓
|
$389.6K |
| Apr 8, 2015 |
Apr 9, 2015 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
60.0
|
+2,500
|
0.18%
|
✗
|
$74.9K |
| Jul 7, 2014 |
Jul 16, 2014 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
47.5
|
+1,000
|
0.02%
|
✓
|
$9.5K |
| Jul 7, 2014 |
Jul 9, 2014 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
48.8
|
+2,000
|
0.04%
|
✓
|
$19K |
| Jun 30, 2014 |
Jul 2, 2014 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
48.8
|
+2,000
|
0.04%
|
✓
|
$18.3K |
| Jun 23, 2014 |
Jun 25, 2014 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
48.8
|
+2,000
|
0.04%
|
✓
|
$17.6K |
| Jun 16, 2014 |
Jun 18, 2014 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
48.8
|
+2,000
|
0.04%
|
✓
|
$17K |
| Jun 9, 2014 |
Jun 11, 2014 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
48.8
|
+2,000
|
0.04%
|
✓
|
$15.2K |
| Jun 2, 2014 |
Jun 3, 2014 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
48.8
|
+2,000
|
0.04%
|
✓
|
$14.6K |
| May 27, 2014 |
May 29, 2014 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
48.8
|
+2,000
|
0.04%
|
✓
|
$15K |
| May 19, 2014 |
May 21, 2014 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
48.8
|
+2,000
|
0.04%
|
✓
|
$14.7K |
| May 20, 2014 |
May 21, 2014 |
Verastem, Inc.
|
Director |
Buy |
55.0
|
+1,000
|
0.14%
|
✗
|
$8.4K |
| Mar 7, 2014 |
Mar 11, 2014 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
87.5
|
+100,000
|
2.26%
|
✗
|
$1M |
| Nov 11, 2013 |
Nov 12, 2013 |
Verastem, Inc.
|
Director |
Buy |
48.8
|
+1,000
|
0.03%
|
✓
|
$10.9K |
| Nov 4, 2013 |
Nov 4, 2013 |
Verastem, Inc.
|
Director |
Buy |
48.8
|
+1,000
|
0.03%
|
✓
|
$10.5K |
| Oct 28, 2013 |
Oct 28, 2013 |
Verastem, Inc.
|
Director |
Buy |
48.8
|
+1,000
|
0.03%
|
✓
|
$11.3K |
| Oct 21, 2013 |
Oct 21, 2013 |
Verastem, Inc.
|
Director |
Buy |
48.8
|
+1,000
|
0.03%
|
✓
|
$12.6K |
| Oct 14, 2013 |
Oct 15, 2013 |
Verastem, Inc.
|
Director |
Buy |
48.8
|
+1,000
|
0.03%
|
✓
|
$10.6K |
| Oct 7, 2013 |
Oct 7, 2013 |
Verastem, Inc.
|
Director |
Buy |
48.8
|
+1,000
|
0.03%
|
✓
|
$11.5K |
| Sep 30, 2013 |
Sep 30, 2013 |
Verastem, Inc.
|
Director |
Buy |
48.8
|
+1,000
|
0.03%
|
✓
|
$12.6K |
| Sep 23, 2013 |
Sep 23, 2013 |
Verastem, Inc.
|
Director |
Buy |
48.8
|
+1,000
|
0.03%
|
✓
|
$13.2K |
| Sep 16, 2013 |
Sep 16, 2013 |
Verastem, Inc.
|
Director |
Buy |
48.8
|
+1,000
|
0.03%
|
✓
|
$13.8K |
| Sep 11, 2013 |
Sep 12, 2013 |
Tempest Therapeutics, Inc.
|
Director |
Buy |
60.0
|
+4,850
|
0.11%
|
✗
|
$51.1K |
| Sep 9, 2013 |
Sep 9, 2013 |
Verastem, Inc.
|
Director |
Buy |
48.8
|
+1,000
|
0.03%
|
✓
|
$14K |
| Sep 3, 2013 |
Sep 3, 2013 |
Verastem, Inc.
|
Director |
Buy |
48.8
|
+1,000
|
0.03%
|
✓
|
$14.1K |
| Aug 26, 2013 |
Aug 26, 2013 |
Verastem, Inc.
|
Director |
Buy |
48.8
|
+1,000
|
0.03%
|
✓
|
$14.2K |
| Aug 19, 2013 |
Aug 19, 2013 |
Verastem, Inc.
|
Director |
Buy |
48.8
|
+1,000
|
0.03%
|
✓
|
$13.5K |
| Aug 12, 2013 |
Aug 12, 2013 |
Verastem, Inc.
|
Director |
Buy |
48.8
|
+1,000
|
0.03%
|
✓
|
$14.8K |
| Aug 5, 2013 |
Aug 5, 2013 |
Verastem, Inc.
|
Director |
Buy |
48.8
|
+1,000
|
0.03%
|
✓
|
$15.3K |
| Jul 29, 2013 |
Jul 29, 2013 |
Verastem, Inc.
|
Director |
Buy |
48.8
|
+1,000
|
0.03%
|
✓
|
$15.2K |
| Jul 24, 2013 |
Jul 24, 2013 |
Verastem, Inc.
|
Director |
Buy |
48.8
|
+1,000
|
0.03%
|
✓
|
$16.4K |
| Jul 15, 2013 |
Jul 15, 2013 |
Verastem, Inc.
|
Director |
Buy |
48.8
|
+1,000
|
0.03%
|
✓
|
$17.2K |
| Jul 8, 2013 |
Jul 10, 2013 |
Verastem, Inc.
|
Director |
Buy |
48.8
|
+1,000
|
0.03%
|
✓
|
$14.7K |
| Jul 1, 2013 |
Jul 2, 2013 |
Verastem, Inc.
|
Director |
Buy |
48.8
|
+1,000
|
0.03%
|
✓
|
$14.1K |
| Apr 15, 2008 |
Apr 17, 2008 |
CURIS INC
|
10% Owner |
Sell |
17.5
|
-1,300,000
|
-17.22%
|
✗
|
$1.8M |